Open-Label Multicentre Study on Efficacy and Safety of Oral Quetiapine (Seroquel XR) in Adults With Schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 16 Jul 2012
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors AstraZeneca
- 19 Jul 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 Jan 2010 Planned end date changed from 1 Mar 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 02 Mar 2009 New trial record